DROSHA and myelodysplastic syndrome: Our findings demonstrate that dysregulation of key miRNA biogenesis genes, particularly DROSHA, DICER1, DGCR8, and TARBP2, is associated with hematopoietic disruption in newly diagnosed MDS and AML patients.